Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

Keytruda is also approved for first-line use alongside chemo and trastuzumab in HER2-positive gastric and GEJ cancers. Gilead and Arcus are already running the phase 3 STAR-221 trial of their ...

In the meantime, Cabometyx should continue being a star performer for Exelixis ... That beat Merck's cancer immunotherapy Keytruda. To put this into context, Keytruda generated sales of $25 billion ...

The safety and overall survival seen in the ARC-10 trial lends further support to the firm's strategy of pairing domvanalimab and zimberelimab with chemo in STAR-121.

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

More recent acquisitions in 2024—oncology firms Mirati and RayzeBio and neurology firm Karuna—also help support Bristol's strong overall pipeline and wide moat. Bristol has created a strong pipeline ...

While immunotherapies have transformed treatment of many types of cancer, they do sometimes fail to have an impact – as Merck & Co has just observed in a study of Keytruda in head and neck cancer.

Nov. 4, 2024 — The temperature of elementary particles has been observed in the radioactive glow following the collision of two neutron stars and the birth of a black hole. This has, for the ...

Moderna Inc.'s stock was higher but off its early highs Thursday, after the company's third-quarter earnings showed an unexpected profit as well as revenue that beat estimates by a wide margin. The ...

New analyses include... at 07:00 Medicenna Announces Positive Single-Agent Activity of MDNA11 from Dose Expansion Cohort and Encouraging Safety Profile in Combination with KEYTRUDA® (pembrolizumab) at ...

Cecily Strong and her fiancé, Jack, are expecting their first child, the “Saturday Night Live” star announced on Nov. 1. The comedian shared the exciting news on Instagram, revealing she got ...